US push to cut drug prices could mean longer waits for European patients
- European: 102 events in the last 90 days
- Previous: earlier the same day · Wade ends 10-year European title drought with victory in Flanders
What happened
Europe’s patients could face longer waits for some new medicines as US efforts to drive down drug prices risk encouraging pharmaceutical companies to delay launches in lower-price markets, according to a new modelling study.
Summary assembled by rule from the sources below